UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 2, 2011
Apricus Biosciences, Inc.
(Exact name of registrant as specified in its charter)
| | | | |
Nevada | | 0-22245 | | 87-0449967 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
6330 Nancy Ridge Drive, Suite 103, San Diego, California | | 92121 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (858) 222-8041
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On September 2, 2011, Apricus Biosciences, Inc. issued a press release correcting the terminology relating to its over-the-counter products. A copy of the release is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibit is filed with this report on Form 8-K:
| | |
Exhibit Number | | Description of Exhibit |
| | |
99.1 | | Press Release, dated September 2, 2011. |
| | |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
September 2, 2011 | Apricus Biosciences, Inc. | |
| By: | /s/ Randy Berholtz | |
| | Randy Berholtz | |
| | Executive Vice President, General Counsel and Secretary | |
| | |
Exhibit Number | | Description of Exhibit |
| | |
99.1 | | Press Release, dated September 2, 2011. |